These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 17461877)

  • 1. Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome.
    Chinushi M; Komura S; Izumi D; Furushima H; Tanabe Y; Washizuka T; Aizawa Y
    Pacing Clin Electrophysiol; 2007 May; 30(5):662-71. PubMed ID: 17461877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome.
    Ikeda T; Abe A; Yusu S; Nakamura K; Ishiguro H; Mera H; Yotsukura M; Yoshino H
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):602-7. PubMed ID: 16836706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia.
    Ueyama T; Shimizu A; Esato M; Yoshiga Y; Sawa A; Suzuki S; Sugi N; Matsuzaki M
    Europace; 2008 Jan; 10(1):86-90. PubMed ID: 18037690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
    Nagase S; Kusano KF; Morita H; Nishii N; Banba K; Watanabe A; Hiramatsu S; Nakamura K; Sakuragi S; Ohe T
    J Am Coll Cardiol; 2008 Mar; 51(12):1154-61. PubMed ID: 18355652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conduction delay in right ventricle as a marker for identifying high-risk patients with Brugada syndrome.
    Doi A; Takagi M; Maeda K; Tatsumi H; Shimeno K; Yoshiyama M
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):688-96. PubMed ID: 20050961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular late potential in patients with apparently normal electrocardiogram; predictor of Brugada syndrome.
    Mizobuchi M; Enjoji Y; Nakamura S; Muranishi H; Utsunomiya M; Funatsu A; Kobayashi T
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):266-73. PubMed ID: 19954504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
    Tada T; Kusano KF; Nagase S; Banba K; Miura D; Nishii N; Watanabe A; Nakamura K; Morita H; Ohe T
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):56-61. PubMed ID: 17916151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of ST elevation and ventricular arrhythmias in an experimental Brugada syndrome model.
    Kimura M; Kobayashi T; Owada S; Ashikaga K; Higuma T; Sasaki S; Iwasa A; Motomura S; Okumura K
    Circulation; 2004 Jan; 109(1):125-31. PubMed ID: 14662710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple premature beats triggered ventricular arrhythmias during pilsicainide infusion in a patient with inferior ST-segment elevation.
    Chinushi M; Izumi D; Furushima H; Watanabe H; Aizawa Y
    Pacing Clin Electrophysiol; 2006 Dec; 29(12):1445-8. PubMed ID: 17201857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What variables were associated with the inducibility of ventricular fibrillation during electrophysiologic stimulation test in patients without apparent organic heart disease?
    Sugi N; Shimizu A; Ueyama T; Yoshiga Y; Doi M; Ohmiya T; Ohno M; Yoshida M; Matsuzaki M
    J Cardiol; 2010 Jul; 56(1):35-43. PubMed ID: 20350514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilsicainide-induced ST segment elevation and ST segment depression in two patients with variant forms of Brugada-type electrocardiographic abnormalities.
    Chinushi M; Tagawa M; Izumi D; Furushima H; Aizawa Y
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):811-5. PubMed ID: 19545347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Brugada syndrome associated with ventricular fibrillation induced by administration of pilsicainide: a case report].
    Matsumoto K; Sumita S; Ishikawa T; Matsushita K; Kobayashi T; Ohkusu Y; Yamakawa Y; Nakagawa T; Nakazawa I; Mochida Y; Ebina T; Uchino K; Kimura K; Umemura S
    J Cardiol; 2003 Nov; 42(5):227-34. PubMed ID: 14658412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study.
    Aiba T; Shimizu W; Hidaka I; Uemura K; Noda T; Zheng C; Kamiya A; Inagaki M; Sugimachi M; Sunagawa K
    J Am Coll Cardiol; 2006 May; 47(10):2074-85. PubMed ID: 16697328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan.
    Takagi M; Yokoyama Y; Aonuma K; Aihara N; Hiraoka M;
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1244-51. PubMed ID: 17900255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between depolarization abnormality and repolarization abnormality in patients with Brugada syndrome: using body surface signal-averaged electrocardiography and body surface maps.
    Hisamatsu K; Kusano KF; Morita H; Takenaka S; Nagase S; Nakamura K; Emori T; Matsubara H; Mikouchi H; Nishizaki Y; Ohe T
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):870-6. PubMed ID: 15333077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome.
    Morita H; Morita ST; Nagase S; Banba K; Nishii N; Tani Y; Watanabe A; Nakamura K; Kusano KF; Emori T; Matsubara H; Hina K; Kita T; Ohe T
    J Am Coll Cardiol; 2003 Nov; 42(9):1624-31. PubMed ID: 14607450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial distribution of repolarization and depolarization abnormalities evaluated by body surface potential mapping in patients with Brugada syndrome.
    Yokokawa M; Takaki H; Noda T; Satomi K; Suyama K; Kurita T; Kamakura S; Shimizu W
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1112-21. PubMed ID: 17038144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.
    Kakihara J; Takagi M; Hayashi Y; Tatsumi H; Doi A; Yoshiyama M
    Heart Vessels; 2017 Sep; 32(9):1151-1159. PubMed ID: 28364267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brugada syndrome and idiopathic left ventricular tachycardia unmasked by exercise and a class Ic drug.
    Yuasa S; Sato M; Kitazawa H; Okabe M; Komatsu Y; Koshikawa T; Miyajima S; Aizawa Y
    J Electrocardiol; 2014; 47(5):721-4. PubMed ID: 24908473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.